LeMaitre Vascular shrugged off slower sales during the first three months of 2009 to narrow its net loss, but restructuring charges kept the company out of the black.
The Burlington-based company, which makes a wide array of products and implants for vascular disease, said sales fell slightly during the first quarter, reaching $11.4 million compared with $11.8 million during the same period last year — a 4 percent slip.
